Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

2.47
Delayed Data
As of Jul 22
 +0.0682 / +2.84%
Today’s Change
1.92
Today|||52-Week Range
5.29
-29.13%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close2.40
Today’s open2.43
Day’s range2.43 - 2.50
Volume799
Average volume (3 months)20,655
Market cap$27.2M
Dividend yield--
Data as of 3:19pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-398.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-26.84%
P/E ratioNM
Price/Sales9.10
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
BLPHBellerophon Therapeu...-0.12-6.09%
OGENOragenics Inc+0.01+1.49%
PRPHProPhase Labs Inc0.000.00%
ABIOARCA Biopharma Inc-0.00-0.04%
Data as of 3:59pm ET, 07/22/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$2.7M
Annual profit (last year)-$12.6M
Net profit margin-466.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts

Partner Offers

Search for Jobs